510(k) K202300
K202300 is an FDA 510(k) premarket notification submitted by Optellum, Ltd. for the device "Optellum Virtual Nodule Clinic, Optellum software, Optellum platform". The FDA issued a decision of Substantially Equivalent on March 5, 2021. The device falls under product code POK (Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer), a Class II device regulated under 21 CFR 892.2060.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 5, 2021
- Date Received
- August 13, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer
- Device Class
- Class II
- Regulation Number
- 892.2060
- Review Panel
- RA
- Submission Type
Assist users in characterizing lesions identified on acquired medical images